Clinically Significant Drug Interactions with Newer Antidepressants

Metabolic Drug Interactions Between Antidepressants and Anticancer Drugs: Focus on Selective Serotonin Reuptake Inhibitors and Hypericum Extract

(2013) Filippo Caraci et al.   CURRENT DRUG METABOLISM

Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine

(2011) Corbin J. Bachmeier et al.   BIOPHARMACEUTICS & DRUG DISPOSITION

Duloxetine

(2011) Mary Pat Knadler et al.   CLINICAL PHARMACOKINETICS

Transporter-Mediated Drug–Drug Interactions

(2011) L Zhang et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Vilazodone

(2011) James E. Frampton   CNS DRUGS

Focus on agomelatine

(2011) Ben Green   CURRENT MEDICAL RESEARCH AND OPINION

Antidepressant Use in Geriatric Populations: The Burden of Side Effects and Interactions and Their Impact on Adherence and Costs

(2010) Tami L. Mark et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers

(2010) Adriana Rocha et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The use of antidepressants and the risk of haemorrhagic stroke: a nested case control study

(2010) Ian Douglas et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Escitalopram

(2010) Karly P. Garnock-Jones et al.   CNS DRUGS

The FDA Alert on Serotonin Syndrome With Use of Triptans Combined With Selective Serotonin Reuptake Inhibitors or Selective Serotonin-Norepinephrine Reuptake Inhibitors: American Headache Society Position Paper

(2010) Randolph W. Evans et al.   HEADACHE

The use of antidepressants in clinical practice: focus on agomelatine

(2010) R. H. McAllister-Williams et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Dose-Related Reduction in Bupropion Plasma Concentrations by Ritonavir

(2010) Joohyun Park et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Noradrenergic Adverse Effects Due to Combined Treatment With Reboxetine and Triiodothyronine

(2010) Rena Cooper-Kazaz et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Clinically Relevant Pharmacokinetic Interaction Between Venlafaxine and Bupropion

(2010) Georgios Paslakis et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Effect of Adjunctive Duloxetine on the Plasma Concentrations of Clozapine, Olanzapine, and Risperidone in Patients With Psychotic Disorders

(2010) Vincenza Santoro et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Erratum: Agomelatine, the first melatonergic antidepressant: discovery, characterization and development

(2010) Christian de Bodinat et al.   NATURE REVIEWS DRUG DISCOVERY

Mirtazapine abolishes hyperthermia in an animal model of serotonin syndrome

(2010) Katsutoshi Shioda et al.   NEUROSCIENCE LETTERS

Antidepressants: Clinically Relevant Drug Interactions to Be Considered

(2010) Rene Schellander et al.   PHARMACOLOGY

The Effect of Coadministration of Duloxetine on Steady-State Serum Concentration of Risperidone and Aripiprazole: A Study Based on Therapeutic Drug Monitoring Data

(2010) Magnhild Hendset et al.   THERAPEUTIC DRUG MONITORING

Selective Serotonin Reuptake Inhibitors Are Associated With a Modest Increase in the Risk of Upper Gastrointestinal Bleeding

(2009) Laura E Targownik et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients

(2009) Milka Hauta-Aho et al.   ANNALS OF MEDICINE

Interaction between clonidine and escitalopram

(2009) M. Nikolić et al.   BRITISH JOURNAL OF ANAESTHESIA

An Association Between Selective Serotonin Reuptake Inhibitor Use and Serious Upper Gastrointestinal Bleeding

(2009) Michael Dall et al.   Clinical Gastroenterology and Hepatology

Milnacipran

(2009) Chi-Un Pae et al.   CLINICAL NEUROPHARMACOLOGY

In Vitro and In Vivo Evaluations of Cytochrome P450 1A2 Interactions with Duloxetine

(2009) Evelyn D Lobo et al.   CLINICAL PHARMACOKINETICS

Escitalopram Is a Weak Inhibitor of the CYP2D6-Catalyzed O-Demethylation of (+)-Tramadol but Does Not Reduce the Hypoalgesic Effect in Experimental Pain

(2009) L Noehr-Jensen et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Desvenlafaxine: A new serotonin-norepinephrine reuptake inhibitor for the treatment of adults with major depressive disorder

(2009) Richard Perry et al.   CLINICAL THERAPEUTICS

Duloxetine

(2009) Natalie J. Carter et al.   CNS DRUGS

Mirtazapine

(2009) Katherine F. Croom et al.   CNS DRUGS

Vilazodone: A 5-HT1AReceptor Agonist/Serotonin Transporter Inhibitor for the Treatment of Affective Disorders

(2009) Lee A. Dawson et al.   CNS Neuroscience & Therapeutics

Risk of Upper Gastrointestinal Bleeding and the Degree of Serotonin Reuptake Inhibition by Antidepressants

(2009) Xavier Vidal et al.   DRUG SAFETY

Interactions Between Herbal Medicines and Prescribed Drugs

(2009) Angelo A. Izzo et al.   DRUGS

Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression

(2009) Arif Khan   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Effects of Duloxetine on the Pharmacodynamics and Pharmacokinetics of Warfarin at Steady State in Healthy Subjects

(2009) Jill Chappell et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Interactions Between Tamoxifen and Antidepressants via Cytochrome P450 2D6

(2009) Julie Eve Desmarais et al.   JOURNAL OF CLINICAL PSYCHIATRY

Venlafaxine Metabolism as a Marker of Cytochrome P450 Enzyme 2D6 Metabolizer Status

(2009) Alice I. Nichols et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment

(2009) Susanna M Wallerstedt et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Lack of clinically significant interactions between concomitantly administered rasagiline and escitalopram

(2009) Johanna Hilli et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Influence of Comedication on Serum Concentrations of Aripiprazole and Dehydroaripiprazole

(2009) Ragnhild Birkeland Waade et al.   THERAPEUTIC DRUG MONITORING

Rapid Clinical Induction of Hepatic Cytochrome P4502B6 Activity by Ritonavir

(2008) E. D. Kharasch et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Risk of Upper Gastrointestinal Tract Bleeding Associated With Selective Serotonin Reuptake Inhibitors and Venlafaxine Therapy

(2008) Francisco J. de Abajo et al.   ARCHIVES OF GENERAL PSYCHIATRY

Increased Bleeding Risk With Concurrent Use of Selective Serotonin Reuptake Inhibitors and Coumarins

(2008) Tom Schalekamp   ARCHIVES OF INTERNAL MEDICINE

Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look

(2008) Lucie Opatrny et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Steady-State Concentrations of Mirtazapine, N-Desmethylmirtazapine, 8-Hydroxymirtazapine and their Enantiomers in Relation to Cytochrome P450 2D6 Genotype, Age and Smoking Behaviour

(2008) Anna-Britta Lind et al.   CLINICAL PHARMACOKINETICS

Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update

(2008) Edoardo Spina et al.   CLINICAL THERAPEUTICS

Desvenlafaxine Extended Release

(2008) Lily P H Yang et al.   CNS DRUGS

An in Vitro Mechanistic Study to Elucidate the Desipramine/Bupropion Clinical Drug-Drug Interaction

(2008) M. J. Reese et al.   DRUG METABOLISM AND DISPOSITION

An Assessment of Drug-Drug Interactions: The Effect of Desvenlafaxine and Duloxetine on the Pharmacokinetics of the CYP2D6 Probe Desipramine in Healthy Subjects

(2008) A. Patroneva et al.   DRUG METABOLISM AND DISPOSITION

Bupropion

(2008) Sohita Dhillon et al.   DRUGS

Factors potentiating the risk of mirtazapine-associated restless legs syndrome

(2008) Sung-Wan Kim et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

The Effects of Desvenlafaxine and Paroxetine on the Pharmacokinetics of the Cytochrome P450 2D6 Substrate Desipramine in Healthy Adults

(2008) Alice I. Nichols et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Restless legs syndrome as side effect of second generation antidepressants

(2008) Klaus G. Rottach et al.   JOURNAL OF PSYCHIATRIC RESEARCH

The Influence of Smoking on the Serum Level of Duloxetine

(2008) M. Fric et al.   PHARMACOPSYCHIATRY